Order Article Reprints

Frost M, Keable A, Baseley D, Sealy A, Andreea Zbarcea D, Gatherer M, Yuen HM, Sharp MM, Weller RO, Attems J, et al. Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer’s Disease. Pharmaceuticals. 2020; 13(9):261. https://doi.org/10.3390/ph13090261

Frost, Miles, Abby Keable, Dan Baseley, Amber Sealy, Diana Andreea Zbarcea, Maureen Gatherer, Ho Ming Yuen, Matt MacGregor Sharp, Roy O. Weller, Johannes Attems, and et al. 2020. "Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer’s Disease" Pharmaceuticals 13, no. 9: 261. https://doi.org/10.3390/ph13090261

Frost, M., Keable, A., Baseley, D., Sealy, A., Andreea Zbarcea, D., Gatherer, M., Yuen, H. M., Sharp, M. M., Weller, R. O., Attems, J., Smith, C., Chiarot, P. R., & Carare, R. O. (2020). Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer’s Disease. Pharmaceuticals, 13(9), 261. https://doi.org/10.3390/ph13090261